These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 23316603)

  • 1. [Endogenous metabolites--arginine/nitric oxide regulate the body's physiological function].
    Dong WQ; Zhang MX
    Sheng Li Ke Xue Jin Zhan; 2012 Oct; 43(5):334-7. PubMed ID: 23316603
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological effects of arginine metabolites.
    Blantz RC; Satriano J; Gabbai F; Kelly C
    Acta Physiol Scand; 2000 Jan; 168(1):21-5. PubMed ID: 10691775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The L-arginine-nitric oxide system: physiology, physiopathology and clinical relevance].
    Garini G; Savazzi G; Borghetti A
    Recenti Prog Med; 1997 Feb; 88(2):90-9. PubMed ID: 9148375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nitric oxide/cGMP signaling pathway in pulmonary hypertension.
    Klinger JR
    Clin Chest Med; 2007 Mar; 28(1):143-67, ix. PubMed ID: 17338933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy.
    Ognibene DT; Moss MB; Matsuura C; Brunini TM; de Moura RS; Mendes-Ribeiro AC; Resende AC
    Hypertens Res; 2010 Sep; 33(9):899-904. PubMed ID: 20555333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological significance of endogenous nitric oxide.
    Ignarro LJ
    Semin Perinatol; 1991 Feb; 15(1):20-6. PubMed ID: 1676543
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute administration of l-arginine restores nitric oxide-mediated relaxation in isolated pulmonary arteries from pulmonary hypertensive exercise trained rats.
    Goret L; Tanguy S; Guiraud I; Dauzat M; Obert P
    Eur J Pharmacol; 2008 Feb; 581(1-2):148-56. PubMed ID: 18164288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-dependent and -independent mechanisms of vasodilation in pregnancy.
    Beilin LJ; Chu ZM
    J Hypertens Suppl; 1993 Dec; 11(5):S148-9. PubMed ID: 7512638
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperoxia and alkalosis produce pulmonary vasodilation independent of endothelium-derived nitric oxide in newborn lambs.
    Fineman JR; Wong J; Soifer SJ
    Pediatr Res; 1993 Apr; 33(4 Pt 1):341-6. PubMed ID: 8479813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nitric oxide: from endogenous vasodilator to biologic mediator].
    Berrazueta JR; López-Jaramillo P; Moncada S
    Rev Esp Cardiol; 1990; 43(7):421-31. PubMed ID: 2093954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin vasodilatation and the "arginine paradox".
    Ueda S; Petrie JR; Cleland SJ; Elliott HL; Connell JM
    Lancet; 1998 Mar; 351(9107):959-60. PubMed ID: 9734951
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute intrauterine pulmonary hypertension impairs endothelium-dependent vasodilation in the ovine fetus.
    Storme L; Rairigh RL; Parker TA; Kinsella JP; Abman SH
    Pediatr Res; 1999 Apr; 45(4 Pt 1):575-81. PubMed ID: 10203151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The L-arginine-NO pathway and cyclic GMP in the vessel wall.
    Stoclet JC
    Z Kardiol; 1991; 80 Suppl 7():87-90. PubMed ID: 1665267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
    Ozturk EI; Uma S
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of pulmonary vascular control in normal and injured lungs.
    McIntyre RC; Harken AH; Fullerton DA
    Surgery; 1994 Mar; 115(3):273-5. PubMed ID: 8128350
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.
    Pearson DL; Dawling S; Walsh WF; Haines JL; Christman BW; Bazyk A; Scott N; Summar ML
    N Engl J Med; 2001 Jun; 344(24):1832-8. PubMed ID: 11407344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical pharmacology of L-arginine.
    Böger RH; Bode-Böger SM
    Annu Rev Pharmacol Toxicol; 2001; 41():79-99. PubMed ID: 11264451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological role of metabolic pathways from L-arginine to nitric oxide].
    Zembowicz A
    Folia Med Cracov; 1992; 33(1-4):103-16. PubMed ID: 1342993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
    Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
    Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.